We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Nixon Peabody, Mintz Levin Blamed For Biotech's Downfall

Law360, New York (July 23, 2014, 12:28 PM EDT) -- A lawsuit filed in New York federal court Tuesday by Neogenix Oncology Inc. against its former executives also targets Nixon Peabody LLP and Mintz Levin Cohn Ferris Glovsky & Popeo PC, alleging breach of fiduciary duty and malpractice and implicating them in the downfall of the now-bankrupt biotech company.

According to the complaint, the company’s former CFO paid commissions to individuals and firms for their sales of Neogenix stock, despite the fact that some of them were not licensed to sell securities. Attorneys from Mintz Levin...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Neogenix Oncology, Inc. v. Gordon et al


Case Number

2:14-cv-04427

Court

New York Eastern

Nature of Suit

Fraud or Truth-In-Lending

Judge

Joseph F. Bianco

Date Filed

July 22, 2014

Law Firms

Government Agencies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.